Heather Biele is a Medical Copy Editor at Healio. She specializes in various aspects of medicine and healthcare, with a focus on topics such as oncology, immunotherapy, digital health, and wellness. Biele's work has been featured in Healio, where she contributes to advancing discussions on health and medical specialties.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Heather's coverage is heavily data-centric, often citing research and medical findings. She appears to be interested in a wide range of healthcare and scientific topics, including medical research, health conditions, treatment options, public health, and patient care.
Given her focus on citing data extensively in her articles and the diverse nature of the topics she covers within healthcare and scientific fields, Heather would likely respond positively to pitches that offer access to new or significant studies with clear implications for patient care or public health.
It seems that Heather doesn't have a specific geographic focus but rather focuses on global trends in healthcare and scientific research. Therefore, sources with insights into international studies or those at the forefront of groundbreaking medical discoveries may pique her interest.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Heather Biele, Mark Leiser
A class of medications widely prescribed to treat ADHD and narcolepsy can confer modest but consistent reductions in cancer-related fatigue, according to results of a systematic review and meta-analysis of randomized trials.
By: Heather Biele, Matthew Shinkle
The FDA has expanded a safety alert warning consumers to avoid certain botanical weight loss supplements that contain toxic yellow oleander.
By: Heather Biele, Josh Friedman
Medically assisted reproduction may increase risk for hormone-related malignancies such as breast and ovarian cancer, but the total number of additional cases appears to be low and could have other explanations.
By: Richard Gawel
Patients with tardive dyskinesia experienced improvements in quality of life and functionality across 24 weeks of treatment with valbenazine, according to a study published in CNS Spectrums. Valbenazine (Ingrezza; Neurocrine Biosciences) is one of two vesicular monoamine transporter 2 inhibitors approved for tardive dyskinesia (TD) treatment, Christoph U. Correll, MD, professor of psychiatry and
By: Josh Friedman, Heather Biele
A telehealth-based smoking cessation program significantly improved quit rates among patients with cancer treated at community practices.
By: Heather Biele
An investigational anti-TL1A monoclonal antibody achieved “clinically meaningful” outcomes compared with placebo in patients with inflammatory bowel disease, according to results of the RELIEVE UCCD trial.
By: Josh Friedman, Heather Biele
Erika L. Rangel, MD, kept her first pregnancy secret for 6 months.
By: Robert Glatter, Heather Biele
When we think about fatty liver, the intuitive culprit is dietary fat. Yet the dominant dietary drivers for metabolic dysfunction-associated steatotic
The FDA has authorized the marketing of 11 Zyn Ultra nicotine pouch products , which it states is an “important step to provide greater access to
By: Heather Biele
A fecal immunochemical testing-based screening program in Spain was linked to durable decline in colorectal cancer mortality over a 21-year period, according to study results published in JAMA Network Open.
